BACKGROUND: Health inequities among people with HIV may be compounded by disparities in the prevalence of comorbidities associated with an increased risk of severe illness from COVID-19. SETTING: Complex sample survey designed to produce nationally representative estimates of behavioral and clinical characteristics of adults with diagnosed HIV in the United States. METHODS: We estimated the prevalence of having ≥1 diagnosed comorbidity associated with severe illness from COVID-19 and prevalence differences (PDs) by race/ethnicity, income level, and type of health insurance. We considered PDs ≥5 percentage points to be meaningful from a public health perspective. RESULTS: An estimated 37.9% [95% confidence interval (CI): 36.6 to 39.2] of adults receiving HIV care had ≥1 diagnosed comorbidity associated with severe illness from COVID-19. Compared with non-Hispanic Whites, non-Hispanic Blacks or African Americans were more likely [adjusted PD, 7.8 percentage points (95% CI: 5.7 to 10.0)] and non-Hispanic Asians were less likely [adjusted PD, -13.7 percentage points (95% CI: -22.3 to -5.0)] to have ≥1 diagnosed comorbidity after adjusting for age differences. There were no meaningful differences between non-Hispanic Whites and adults in other racial/ethnic groups. Those with low income were more likely to have ≥1 diagnosed comorbidity [PD, 7.3 percentage points (95% CI: 5.1 to 9.4)]. CONCLUSIONS: Among adults receiving HIV care, non-Hispanic Blacks and those with low income were more likely to have ≥1 diagnosed comorbidity associated with severe COVID-19. Building health equity among people with HIV during the COVID-19 pandemic may require reducing the impact of comorbidities in heavily affected communities.
BACKGROUND: Health inequities among people with HIV may be compounded by disparities in the prevalence of comorbidities associated with an increased risk of severe illness from COVID-19. SETTING: Complex sample survey designed to produce nationally representative estimates of behavioral and clinical characteristics of adults with diagnosed HIV in the United States. METHODS: We estimated the prevalence of having ≥1 diagnosed comorbidity associated with severe illness from COVID-19 and prevalence differences (PDs) by race/ethnicity, income level, and type of health insurance. We considered PDs ≥5 percentage points to be meaningful from a public health perspective. RESULTS: An estimated 37.9% [95% confidence interval (CI): 36.6 to 39.2] of adults receiving HIV care had ≥1 diagnosed comorbidity associated with severe illness from COVID-19. Compared with non-Hispanic Whites, non-Hispanic Blacks or African Americans were more likely [adjusted PD, 7.8 percentage points (95% CI: 5.7 to 10.0)] and non-Hispanic Asians were less likely [adjusted PD, -13.7 percentage points (95% CI: -22.3 to -5.0)] to have ≥1 diagnosed comorbidity after adjusting for age differences. There were no meaningful differences between non-Hispanic Whites and adults in other racial/ethnic groups. Those with low income were more likely to have ≥1 diagnosed comorbidity [PD, 7.3 percentage points (95% CI: 5.1 to 9.4)]. CONCLUSIONS: Among adults receiving HIV care, non-Hispanic Blacks and those with low income were more likely to have ≥1 diagnosed comorbidity associated with severe COVID-19. Building health equity among people with HIV during the COVID-19 pandemic may require reducing the impact of comorbidities in heavily affected communities.
Authors: Rachel A Bender Ignacio; Adrienne E Shapiro; Robin M Nance; Bridget M Whitney; Joseph A C Delaney; Laura Bamford; Darcy Wooten; Maile Y Karris; William C Mathews; Hyang Nina Kim; Jeanne Keruly; Greer Burkholder; Sonia Napravnik; Kenneth H Mayer; Jeffrey Jacobson; Michael Saag; Richard D Moore; Joseph J Eron; Amanda L Willig; Katerina A Christopoulos; Jeffrey Martin; Peter W Hunt; Heidi M Crane; Mari M Kitahata; Edward R Cachay Journal: AIDS Date: 2022-05-06 Impact factor: 4.632
Authors: Christopher L Bennett; Emmanuel Ogele; Nicholas R Pettit; Jason J Bischof; Tong Meng; Prasanthi Govindarajan; Carlos A Camargo; Kristen Nordenholz; Jeffrey A Kline Journal: J Acquir Immune Defic Syndr Date: 2021-12-01 Impact factor: 3.771
Authors: Henry F Raymond; Pratik Datta; Rahul Ukey; Peng Wang; Richard J Martino; Kristen D Krause; Corey Rosmarin-DeStefano; Abraham Pinter; Perry N Halkitis; Maria L Gennaro Journal: J Racial Ethn Health Disparities Date: 2021-11-08
Authors: R A Bender Ignacio; A E Shapiro; R M Nance; B M Whitney; Jac Delaney; L Bamford; D Wooten; M Karris; W C Mathews; H N Kim; S E Van Rompaey; J C Keruly; G Burkholder; S Napravnik; K H Mayer; J Jacobson; M S Saag; R D Moore; J J Eron; A L Willig; K A Christopoulos; J Martin; P W Hunt; H M Crane; M M Kitahata; E Cachay Journal: medRxiv Date: 2021-12-08
Authors: Cecilia T Costiniuk; Joel Singer; Marc-André Langlois; Iva Kulic; Judy Needham; Ann Burchell; Mohammad-Ali Jenabian; Sharon Walmsley; Mario Ostrowski; Colin Kovacs; Darrell Tan; Marianne Harris; Mark Hull; Zabrina Brumme; Mark Brockman; Shari Margolese; Enrico Mandarino; Jonathan B Angel; Jean-Pierre Routy; Aslam H Anis; Curtis Cooper Journal: BMJ Open Date: 2021-12-16 Impact factor: 2.692
Authors: Anne K Monroe; Jiayang Xiao; Alan E Greenberg; Matt E Levy; Marinella Temprosa; Jenna B Resnik; Amanda D Castel Journal: AIDS Behav Date: 2022-04-13